Skip to Content
Merck
  • Chromobacterium violaceum ω-transaminase variant Trp60Cys shows increased specificity for (S)-1-phenylethylamine and 4'-substituted acetophenones, and follows Swain-Lupton parameterisation.

Chromobacterium violaceum ω-transaminase variant Trp60Cys shows increased specificity for (S)-1-phenylethylamine and 4'-substituted acetophenones, and follows Swain-Lupton parameterisation.

Organic & biomolecular chemistry (2012-06-13)
Karim Engelmark Cassimjee, Maria Svedendahl Humble, Henrik Land, Vahak Abedi, Per Berglund
ABSTRACT

For biocatalytic production of pharmaceutically important chiral amines the ω-transaminase enzymes have proven useful. Engineering of these enzymes has to some extent been accomplished by rational design, but mostly by directed evolution. By use of a homology model a key point mutation in Chromobacterium violaceum ω-transaminase was found upon comparison with engineered variants from homologous enzymes. The variant Trp60Cys gave increased specificity for (S)-1-phenylethylamine (29-fold) and 4'-substituted acetophenones (∼5-fold). To further study the effect of the mutation the reaction rates were Swain-Lupton parameterised. On comparison with the wild type, reactions of the variant showed increased resonance dependence; this observation together with changed pH optimum and cofactor dependence suggests an altered reaction mechanism.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
(R)-(+)-α-Methylbenzylamine, purum, ≥98.0% (sum of enantiomers, GC)
Supelco
(R)-(+)-α-Methylbenzylamine, for chiral derivatization, LiChropur, ≥99.0%
Sigma-Aldrich
α-Methylbenzylamine, 99%
Sigma-Aldrich
(R)-(+)-α-Methylbenzylamine, 98%
Sigma-Aldrich
(R)-(+)-α-Methylbenzylamine, ChiPros®, produced by BASF, ≥99.0%
Sigma-Aldrich
(S)-(−)-α-Methylbenzylamine, 98%